Bart Welten

Nessuna posizione attualmente

64 anni

Consumer Services

Health Technology

Producer Manufacturing

Profilo

Bart Welten served as Chief Financial Officer at Avantium NV from 2020 to 2023, at DSM Resins BV from 2006 to 2012, and at Centrient Pharmaceuticals Netherlands BV in 2018-2019.
He also held the position of Chief Financial Officer at DSM Anti Infectives BV.
Mr. Welten holds an MBA from Boston College and an undergraduate degree from the University of Leiden.

Precedenti posizioni note di Bart Welten

Società	Posizione	Fine
AVANTIUM N.V.	Director of Finance/CFO	01/01/2023
Centrient Pharmaceuticals Netherlands BV Centrient Pharmaceuticals Netherlands BV BiotechnologyHealth Technology Centrient Pharmaceuticals Netherlands BV produces green beta-lactams antibiotics. It offers active pharmaceutical ingredients and drug products for anti-infectives such as antibiotics, anti-fungals and other therapeutic classes like cholesterol lowering medicines. The company was founded in 1869 and is headquartered in Delft, the Netherlands.	Director of Finance/CFO	01/02/2019
DSM Resins BV	Director of Finance/CFO	01/07/2012
DSM Anti Infectives BV DSM Anti Infectives BV Pharmaceuticals: MajorHealth Technology Part of DSM BV, DSM Anti Infectives BV is a Dutch company that manufactures ingredients for antibiotics. The private company is based in Delft, the Netherlands. DSM Anti Infectives was acquired by Sinochem Group Co., Ltd. from DSM BV on August 31, 2011 for $277.08 million.	Director of Finance/CFO	-

Vedi nel dettaglio l'esperienza di Bart Welten

Formazione di Bart Welten

Boston College	Masters Business Admin
University of Leiden	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Bart Welten

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
AVANTIUM N.V.	Producer Manufacturing

Aziende private	3
DSM Resins BV
Centrient Pharmaceuticals Netherlands BV Centrient Pharmaceuticals Netherlands BV BiotechnologyHealth Technology Centrient Pharmaceuticals Netherlands BV produces green beta-lactams antibiotics. It offers active pharmaceutical ingredients and drug products for anti-infectives such as antibiotics, anti-fungals and other therapeutic classes like cholesterol lowering medicines. The company was founded in 1869 and is headquartered in Delft, the Netherlands.	Health Technology
DSM Anti Infectives BV DSM Anti Infectives BV Pharmaceuticals: MajorHealth Technology Part of DSM BV, DSM Anti Infectives BV is a Dutch company that manufactures ingredients for antibiotics. The private company is based in Delft, the Netherlands. DSM Anti Infectives was acquired by Sinochem Group Co., Ltd. from DSM BV on August 31, 2011 for $277.08 million.	Health Technology

Vedi le connessioni aziendali